Martin Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
25,624
+700
| +3% | +$54.7K | 1.3% | 23 |
|
|
2025
Q1 | $1.81M | Sell |
24,924
-622
| -2% | -$45.1K | 1.29% | 23 |
|
|
2024
Q4 | $1.89M | Hold |
25,546
| – | – | 1.22% | 24 |
|
|
2024
Q3 | $1.69M | Buy |
25,546
+186
| +0.7% | +$12.3K | 1.2% | 24 |
|
|
2024
Q2 | $2.34M | Sell |
25,360
-130
| -0.5% | -$12K | 1.76% | 15 |
|
|
2024
Q1 | $2.44M | Hold |
25,490
| – | – | 1.91% | 15 |
|
|
2023
Q4 | $1.94M | Buy |
25,490
+128
| +0.5% | +$9.76K | 1.64% | 19 |
|
|
2023
Q3 | $1.76M | Buy |
25,362
+880
| +4% | +$61K | 1.71% | 17 |
|
|
2023
Q2 | $2.31M | Buy |
24,482
+257
| +1% | +$24.2K | 2.11% | 11 |
|
|
2023
Q1 | $2M | Sell |
24,225
-1,485
| -6% | -$123K | 2.07% | 13 |
|
|
2022
Q4 | $1.92M | Buy |
25,710
+3,401
| +15% | +$254K | 2.14% | 13 |
|
|
2022
Q3 | $1.84M | Sell |
22,309
-17,900
| -45% | -$1.48M | 2.71% | 8 |
|
|
2022
Q2 | $3.82M | Hold |
40,209
| – | – | 3.37% | 6 |
|
|
2022
Q1 | $4.73M | Buy |
40,209
+300
| +0.8% | +$35.3K | 3.24% | 7 |
|
|
2021
Q4 | $5.17M | Buy |
+39,909
| New | +$5.17M | 3.2% | 6 |
|